Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name CCHE1
   Synonyms CCEPR, CCHE1, lncRNA-CCHE1
   Region NA    Sequence
   Ensembl NA
   RefSeq NR_131782
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name hepatocellular carcinoma
   ICD-0-3 C22.0  M8170/3
   Methods qPCR, RNAi, Flow cytometry assay, MTT assay etc.
   Sample HCC tissues, cell lines (MHCC97H, Huh-7, Hep3B, HepG2 and HCCLM3)
   Expression Pattern up-regulated
   Function Description

The level of CCHE1 expressed in all five HCC cell lines was significantly higher than the normal hepatocyte L02 cells. The higher expression of CCHE1 was significantly correlated with tumor number, tumor size and TNM stage. Multivariate analyses revealed that CCHE1 expression served as an independent predictor for overall survival. Moreover, the effect of CCHE1 on proliferation was evaluated by MTT assays, and cell apoptosis was detected by flow-cytometric analysis. Further experiments demonstrated that CCHE1 knockdown significantly promoted growth arrest and cell apoptosis. Importantly, we further confirmed that ERK/MAPK pathway was found to be inactivated in the HCC cells after CCHE1 knockdown.

   Pubmed ID 27427851
   Year 2016
   Title Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK/MAPK pathway.
   External Links
   Links for  CCHE1 GenBank       HGNC       lncrnadb       Noncode
   Links for  hepatocellular carcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.